Stocks›Healthcare

Amkay Products Limited

AMKAY · BSE · Healthcare · As of 4 Nov 2026

₹53.50

+₹0.50 (+0.94%)(1D)

₹43.0052 Week Range₹81.99

Market Cap

₹49.51 Cr

P/E (Sector)

20.0 (32.3)

P/B Ratio

—

Dividend Yield

—

ROE

26.7%

Debt / Equity

—

Anvest Score

54/100

Valuation

0/100

Quality

100/100

Growth

19/100

Health

100/100

Momentum

46/100

Valuation
0
Quality
100
Growth
19
Health
100
Momentum
46

AI Company ProfileFiling-backed

AI Snapshot

Amkay Products Ltd operates in the healthcare sector, specializing in medical equipment and supplies.

Medical Equipment & SuppliesFounded:2007CEO/MD:Kashyap Pravin ModyHQ:Vasai, Maharashtra

Business profile as of period ended 25 Aug 2026

Revenue growth: +9.5%FY26 growth
PAT growth: -30.8%FY26 growth

What Looks Strong

No material strength identified from currently verified evidence.

What to Watch

EarningsNet profit fell about 31% in FY26 (standalone: ₹3.3 cr → ₹2.3 cr). Watch margins and one-off items in the next filing.
IPOShares trade 51.2% below its first traded close of ₹109.72.

Loading company profile…

Fundamentals

P/E Ratio (TTM)

20.04

Sector median P/E

32.29

P/B Ratio

—

Sector median P/B

4.4

EPS (TTM)

₹2.67

Market Cap

₹49.51 Cr

ROE

26.67%

ROCE

42.03%

Profit Margin

5.41%

Amkay Products Limited FAQs

3 topics

Expand

What does the Amkay Products Limited (AMKAY) stock page cover?

Amkay Products Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for AMKAY?

Amkay Products Limited is currently shown with a delayed price near ₹53.5, P/E 20.04, and ROE 26.67%.

Does the AMKAY page provide investment advice?

No. The AMKAY page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring